Penn Medicine Heart and Vascular Center
- Videos
- Hypertension, Lipids, and Approaches to CV Pharmacologic Risk Reduction 2023
- The Mark E. Josephson Thirtieth Annual State-of-the-Art Arrhythmia Symposium 2023
- Penn Medicine: Case-Based Update on Valvular Heart Disease
- Events
Playback speed
10 seconds
Who Is Appropriate for PCSK-9 Inhibitors, Including Inclisiran?
By
Penn Medicine Heart and Vascular Center
FEATURING
Archna Bajaj
By
Penn Medicine Heart and Vascular Center
FEATURING
Archna Bajaj
557 views
November 21, 2023
Comments 0
Login to view comments.
Click here to Login
Hypertension, Lipids, and Approaches to CV Pharmacologic Risk Reduction 2023